Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |